Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

This can cause the immune response that leads to eczema symptoms. Some specific problems with a part of the immune system called the adaptive immune system probably also contribute to the disease.

Dupixent is already approved in the US for a variety of indications, going back to eczema in 2017 (and most recently for the treatment of the rare skin condition prurigo nodularis), but its ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

That has allowed me to get treatment that has eliminated ... drugs for psoriasis coming out all the time, but Dupixent is the first drug for eczema, and we need more. Meanwhile, a lot of ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

Vulvar eczema may cause dry, itchy skin on the vulva and other parts of the genital area. It’s usually caused by irritants like soaps, chaffing, and wearing tight clothing. Treatments may ...

They could help provide a proper treatment plan for you. Learn more about how to identify, treat, and prevent infected eczema. The exact cause of eczema isn’t known, but research from 2015 ...

If you’re prone to eczema, you don’t want to take any chances with the products you use on your skin—so washing your face ...